Success Metrics

Active Trials
0(0%)

Phase Distribution

Ph not_applicable
5
100%

Phase Distribution

0

Early Stage

0

Mid Stage

0

Late Stage

Phase Distribution5 total trials
N/ANon-phased studies
5(100.0%)

Highest Phase Reached

Unknown

Trial Status & Enrollment

Completion Rate

0.0%

0 of 0 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

0

trials recruiting

Total Trials

5

all time

Status Distribution
Other(5)

Detailed Status

unknown5

Development Timeline

Analytics

Development Status

Total Trials
5
Active
0
Success Rate
N/A
Most Advanced
N/A

Trials by Phase

N/A5 (100.0%)

Trials by Status

unknown5100%

Recent Activity

0 active trials
Showing 5 of 5
unknownnot_applicable

Impact of SPEAC® System Data on Therapeutic Decisions Related to Convulsive Seizure Patients With a Recent Non-diagnostic EMU Visit

NCT03741205
unknownnot_applicable

Detecting PNES With Single-channel sEMG

NCT03313362
unknownnot_applicable

Clinical Utility of the SPEAC® System: A Case Series

NCT03484598
unknownnot_applicable

Impact of SPEAC® System Data on Therapeutic Decisions Related to Convulsive Seizure Patient's Refractory to AEDs

NCT03741192
unknownnot_applicable

Impact of SPEAC® System Data on Therapeutic Decisions Related to Convulsive Seizure Patients With a New Diagnosis

NCT03742661

Clinical Trials (5)

Showing 5 of 5 trials
NCT03741205Not Applicable

Impact of SPEAC® System Data on Therapeutic Decisions Related to Convulsive Seizure Patients With a Recent Non-diagnostic EMU Visit

Unknown
NCT03313362Not Applicable

Detecting PNES With Single-channel sEMG

Unknown
NCT03484598Not Applicable

Clinical Utility of the SPEAC® System: A Case Series

Unknown
NCT03741192Not Applicable

Impact of SPEAC® System Data on Therapeutic Decisions Related to Convulsive Seizure Patient's Refractory to AEDs

Unknown
NCT03742661Not Applicable

Impact of SPEAC® System Data on Therapeutic Decisions Related to Convulsive Seizure Patients With a New Diagnosis

Unknown

All 5 trials loaded

Drug Details

Intervention Type
DEVICE
Total Trials
5